The hSynC – Cell Engineering Product provides a potentially revolutionary next-generation technology to provide transformative cell therapy treatments for human genetic diseases. This means a number of possible application areas that could open up for the technology, allowing for numerous collaboration opportunities alongside high-value licensing opportunities.
Applications in the areas of immune-oncology, metabolic diseases, and neuromuscular diseases are areas of high interest. For further information, we invite you to visit www.cgbioengineering.com for more information.
